Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Citigroup
C
|
+$702M |
| 2 |
Applied Materials
AMAT
|
+$507M |
| 3 |
Keurig Dr Pepper
KDP
|
+$387M |
| 4 |
KeyCorp
KEY
|
+$383M |
| 5 |
Visa
V
|
+$349M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$948M |
| 2 |
Broadcom
AVGO
|
+$446M |
| 3 |
NXP Semiconductors
NXPI
|
+$434M |
| 4 |
Analog Devices
ADI
|
+$309M |
| 5 |
Lam Research
LRCX
|
+$269M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 6.16% |
| 2 | Technology | 4.5% |
| 3 | Industrials | 4.26% |
| 4 | Consumer Discretionary | 4.07% |
| 5 | Healthcare | 3.75% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4276
CALL
IMAX
IMAX
$2.66B
| $1.61M | ﹤0.01% |
72,600
+30,300
| +72% | +$675K |
|
4277
CALL
Fomento Económico Mexicano
FMX
$41.7B
| $1.61M | ﹤0.01% |
18,300
+200
| +1% | +$17.7K |
|
4278
Pebblebrook Hotel Trust
PEB
$2.05B
| $1.61M | ﹤0.01% |
+41,383
| New | +$1.56M |
|
|
ONCE
4279
CALL
DELISTED
Spark Therapeutics, Inc. Common Stock
ONCE
| $1.61M | ﹤0.01% |
19,400
-8,100
| -29% | -$625K |
|
|
GES
4280
PUT
DELISTED
Guess Inc
GES
| $1.6M | ﹤0.01% |
75,000
-20,000
| -21% | -$460K |
|
4281
PUT
Watsco Inc
WSO
$13.6B
| $1.6M | ﹤0.01% |
9,000
+2,200
| +32% | +$400K |
|
4282
Unisys
UIS
$217M
| $1.6M | ﹤0.01% |
124,263
-29,470
| -19% | -$353K |
|
4283
First Trust US Equity Opportunities ETF
FPX
$1.51B
| $1.6M | ﹤0.01% |
+22,430
| New | +$1.59M |
|
4284
Precigen
PGEN
$2.59B
| $1.6M | ﹤0.01% |
114,900
+90,020
| +362% | +$1.52M |
|
4285
CALL
RenaissanceRe
RNR
$13.4B
| $1.6M | ﹤0.01% |
13,300
| – | – |
|
4286
PUT
Acadia Pharmaceuticals
ACAD
$5.03B
| $1.6M | ﹤0.01% |
104,700
+29,400
| +39% | +$524K |
|
4287
W.P. Carey
WPC
$16.4B
| $1.6M | ﹤0.01% |
24,597
+17,449
| +244% | +$1.11M |
|
4288
CALL
GDS Holdings
GDS
$6.41B
| $1.6M | ﹤0.01% |
+39,800
| New | +$1.37M |
|
4289
iShares US Digital Infrastructure and Real Estate ETF
IDGT
$516M
| $1.59M | ﹤0.01% |
+30,472
| New | +$1.59M |
|
|
BPT
4290
PUT
DELISTED
BP Prudhoe Bay Royalty Trust
BPT
| $1.59M | ﹤0.01% |
53,300
+14,300
| +37% | +$369K |
|
4291
PUT
Pacira BioSciences
PCRX
$997M
| $1.59M | ﹤0.01% |
49,700
+7,700
| +18% | +$266K |
|
|
DVAX
4292
PUT
DELISTED
Dynavax Technologies
DVAX
| $1.59M | ﹤0.01% |
104,300
-1,200
| -1% | -$20.7K |
|
4293
CALL
ProShares UltraPro Short Dow 30
SDOW
$137M
| $1.59M | ﹤0.01% |
1,327
-598
| -31% | -$702K |
|
4294
PUT
British American Tobacco
BTI
$128B
| $1.59M | ﹤0.01% |
31,500
+13,100
| +71% | +$690K |
|
4295
Greenlight Captial
GLRE
$506M
| $1.59M | ﹤0.01% |
111,888
+25,001
| +29% | +$381K |
|
4296
PUT
Lithia Motors
LAD
$8.26B
| $1.59M | ﹤0.01% |
16,800
-9,600
| -36% | -$951K |
|
|
SPR
4297
CALL
DELISTED
Spirit AeroSystems
SPR
| $1.59M | ﹤0.01% |
18,500
-2,300
| -11% | -$193K |
|
|
NVRO
4298
CALL
DELISTED
NEVRO CORP.
NVRO
| $1.59M | ﹤0.01% |
19,900
+11,000
| +124% | +$912K |
|
4299
PUT
ProShares Short S&P500
SH
$897M
| $1.58M | ﹤0.01% |
13,500
-8,750
| -39% | -$1.03M |
|
|
REN
4300
CALL
DELISTED
Resolute Energy Corporaton
REN
| $1.58M | ﹤0.01% |
50,700
-8,400
| -14% | -$279K |
|
Similar funds
Citadel Advisors's Q2 2018 Portfolio in Review
As of Q2 2018, Citadel Advisors held 9,765 positions worth $203B, up 11% from $184B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Citadel Advisors deployed $8.95B of net new capital in Q2 2018, opening 1,572 new positions and adding to 4,159 existing holdings. Its largest new stake was Equitable Holdings: 16,008,962 shares worth $330M.
By sector, the portfolio is most concentrated in Financials at 6.2% of assets, up from 4.9% a quarter earlier, followed by Technology and Industrials.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $948M trimmed.
- Citadel Advisors's largest Q2 2018 buy was Equitable Holdings: 16,008,962 shares worth $330M.
- Citadel Advisors added most to Citigroup in Q2 2018, an estimated $702M increase.
- Citadel Advisors's biggest Q2 2018 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $948M.
- Citadel Advisors fully exited Time Warner Inc in Q2 2018, selling an estimated $268M.
- Citadel Advisors's ten largest holdings make up 24% of its $203B portfolio in Q2 2018.
- Citadel Advisors opened 1,572 new positions and closed 1,012 in Q2 2018.
- Citadel Advisors's portfolio value rose 11% quarter-over-quarter to $203B.
Based on Citadel Advisors's 13F filing for Q2 2018, filed 10 Aug 2018.